TRELAGET 100MG TABLET

TRELAGET 100MG TABLET contains Trelagliptin as its active ingredient. It is an oral medication belonging to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors, primarily used in the management of type 2 diabetes mellitus. Trelagliptin helps regulate blood sugar levels by enhancing insulin secretion and decreasing glucagon production in response to meals.

Mechanism of Action:

Trelagliptin exerts its therapeutic effects by inhibiting the enzyme dipeptidyl peptidase-4 (DPP-4), which inactivates incretin hormones such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP). By inhibiting DPP-4, trelagliptin prolongs the action of GLP-1 and GIP, leading to increased insulin secretion and decreased glucagon release from pancreatic alpha cells, thereby lowering blood sugar levels.

Uses:

TRELAGET 100MG TABLET is indicated for the treatment of type 2 diabetes mellitus to improve glycemic control. It is prescribed as an adjunct to diet and exercise in adults when diet and exercise alone do not provide adequate glycemic control. Trelagliptin may be used alone or in combination with other antidiabetic medications, such as metformin or sulfonylureas, depending on the patient’s individual treatment plan.

Dosage and Administration:

The dosage of TRELAGET 100MG TABLET is typically once daily, with or without food. The prescribed dosage may vary based on individual patient factors, including renal function, other medications being taken, and the severity of diabetes. It is essential to follow the healthcare provider’s instructions regarding dosage and administration to achieve optimal glycemic control.

Side Effects:

Common side effects associated with TRELAGET 100MG TABLET may include:

• Hypoglycemia (low blood sugar levels)
• Headache
• Upper respiratory tract infection
• Nasopharyngitis (inflammation of the nasal passages and throat)
• Diarrhea
• Nausea
• Rash

Precautions:

• TRELAGET 100MG TABLET should be used with caution in patients with a history of pancreatitis or severe gastrointestinal disease.
• It is important to monitor blood sugar levels regularly while taking trelagliptin to detect and manage hypoglycemia or hyperglycemia.
• Patients with impaired renal function may require dosage adjustments or additional monitoring while taking trelagliptin.
• Trelagliptin may interact with other medications, so patients should inform their healthcare provider about all current medications, including over-the-counter drugs and supplements.
• Pregnant or breastfeeding women should consult their healthcare provider before taking TRELAGET 100MG TABLET.

Conclusion:

TRELAGET 100MG TABLET, containing Trelagliptin, is a valuable medication used in the management of type 2 diabetes mellitus. By inhibiting DPP-4, trelagliptin helps improve glycemic control by increasing insulin secretion and decreasing glucagon release. While generally well-tolerated, patients should be aware of potential side effects and precautions associated with its use.